Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Sanders

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Oncoimmunology|December 5, 2022
<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Alex van Vliet, Joanna Pozniak, et al.
NPJ Breast Cancer|March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situMathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
Research Square|January 3, 2024
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancerMarcelo Sobral-Leite, Simon Castillo, Shiva Vonk, et al.
Lasers in Surgery and Medicine|December 4, 2019
Using Diffuse Reflectance Spectroscopy to Distinguish Tumor Tissue From Fibrosis in Rectal Cancer Patients as a Guide to SurgeryElisabeth J M Baltussen, Susan G Brouwer de Koning, Joyce Sanders, et al.
Scientific Reports|July 16, 2022
High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrenceSandrine Nugteren, Sjoerd H den Uil, Pien M Delis-van Diemen, et al.
JNCI Cancer Spectrum|May 12, 2021
Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast CancerTessa G Steenbruggen, Michael Schaapveld, Hugo M Horlings, et al.
European Journal of Cancer (Oxford, England : 1990)|March 7, 2024
Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio)Alaa Embaby, Kimberley M Heinhuis, Nikki S IJzerman, et al.
Breast Cancer Research : BCR|November 14, 2023
PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learningWitali Aswolinskiy, Enrico Munari, Hugo M Horlings, et al.
Scientific Reports|May 11, 2026
Crowdsourcing enables robust cell annotation for breast cancer pathologyPascal Klöckner, Melis Erdal Cesur, Bart de Rooij, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Oncoimmunology|December 5, 2022
<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Alex van Vliet, Joanna Pozniak, et al.
NPJ Breast Cancer|March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situMathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
Research Square|January 3, 2024
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancerMarcelo Sobral-Leite, Simon Castillo, Shiva Vonk, et al.
Lasers in Surgery and Medicine|December 4, 2019
Using Diffuse Reflectance Spectroscopy to Distinguish Tumor Tissue From Fibrosis in Rectal Cancer Patients as a Guide to SurgeryElisabeth J M Baltussen, Susan G Brouwer de Koning, Joyce Sanders, et al.
Scientific Reports|July 16, 2022
High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrenceSandrine Nugteren, Sjoerd H den Uil, Pien M Delis-van Diemen, et al.
JNCI Cancer Spectrum|May 12, 2021
Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast CancerTessa G Steenbruggen, Michael Schaapveld, Hugo M Horlings, et al.
European Journal of Cancer (Oxford, England : 1990)|March 7, 2024
Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio)Alaa Embaby, Kimberley M Heinhuis, Nikki S IJzerman, et al.
Breast Cancer Research : BCR|November 14, 2023
PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learningWitali Aswolinskiy, Enrico Munari, Hugo M Horlings, et al.
Scientific Reports|May 11, 2026
Crowdsourcing enables robust cell annotation for breast cancer pathologyPascal Klöckner, Melis Erdal Cesur, Bart de Rooij, et al.
Pageof 9